Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Revance Therapeutics Inc. (RVNC)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 38,541 $500 +173% 0.09%
2.
MFN Partners

Farhad Nanji And Michael Demichele

46,000 $597 0.09%
3.
Sectoral Asset Management

Jerome Pfund And Michael Sjostrom

11,234 $146 0.01%
4. 1,330,973 $17,263 +48% 0.01%
5.
Millennium Management

Israel Englander

0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$31.20 900 Director 6,150 2018-03-16 Filing
$31.25 2,250 Director 5,250 2018-03-16 Filing
$27.45 500 Director 20,000 2017-11-07 Filing
$26.95 19,500 Director 19,500 2017-11-07 Filing
$17.74 780 Officer 14,980 2014-12-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$15.51 11,613 Officer, Director 151,193 2019-03-18 Filing
$15.48 498 Officer 6,400 2019-03-18 Filing
$17.68 5,446 Officer, Director 168,943 2019-02-19 Filing
$17.77 625 Officer 4,000 2019-01-22 Filing
$19.48 375 Officer 4,000 2019-01-03 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 67,141 $873 0.12%
2. 237,000 $3 0.03%
3. 3,250 $42 0%
4. 2,727 $35 0%
5. 1,043 $14 0%
News See All